The finding that the aggressiveness of a thyroid tumor with a TERT promoter mutation may be dependent on the presence of concurrent mutations is an important concept for thyroid specialists to consider when counseling patients regarding risk stratification, management, and extent of surgery. This evidence concerns the gene TERT and thyroid tumor.